Questions: Stimulant and Cannabis Use Disorders

Question 1

A patient says they don't think they have a 'real' addiction because they've never experienced intense physical withdrawal when they stop using cannabis. What is the best clinical response?

• A. The patient is correct — addiction requires significant physiological withdrawal symptoms to be diagnosed.
• B. Cannabis withdrawal is mild but still real; however, addiction diagnosis doesn't require withdrawal — it requires loss of control, continued use despite consequences, and functional impairment.
• C. The patient likely isn't addicted since cannabis affects the endocannabinoid system, which doesn't produce dependence the way opioids or alcohol do.
• D. Withdrawal severity directly maps onto addiction severity, so mild withdrawal indicates mild addiction at worst.

Answer: (B)

The DSM criteria for substance use disorder center on loss of control, continued use despite negative consequences, and impaired functioning — not on withdrawal severity. Cannabis's milder withdrawal compared to opioids or alcohol is the source of the widespread misconception that cannabis isn't addictive. The pattern of use matters, not the intensity of the crash.

Question 2

Why do stimulant users eventually describe using the drug 'not to feel good, but to feel anything at all'?

• A. Stimulants deplete serotonin over time, making positive emotions impossible without the drug.
• B. Long-term stimulant use causes permanent nerve damage that blocks all sensory processing.
• C. Repeated dopamine surges downregulate receptors and degrade baseline dopamine function, leaving natural rewards feeling flat relative to the drug's diminishing returns.
• D. The body builds metabolic tolerance, so the drug is eliminated faster and its effects shorten, requiring more frequent use.

Answer: (C)

Stimulants flood the nucleus accumbens with dopamine far exceeding natural rewards. Over time, dopamine receptors downregulate and baseline dopamine function degrades. Natural rewards (food, connection, achievement) feel anhedonic by comparison — too weak to register on a system calibrated to massive drug-induced surges. The drug itself produces diminishing pleasure, but the degraded baseline means even that diminished effect beats the 'off' state. This is distinct from simple tolerance — it's a recalibration of the reward system itself.

Question 3

Cannabis produces its effects through the same dopamine surge mechanism as stimulants, but acts on different receptors in the nucleus accumbens.

• T. True
• F. False

Answer: False

Cannabis operates through a fundamentally different mechanism. THC binds cannabinoid receptors (CB1), which are spread widely through the prefrontal cortex, hippocampus, basal ganglia, and cerebellum — not primarily through direct dopamine release. CB1 receptors respond normally to endocannabinoids, retrograde messengers that regulate synaptic strength. Stimulants' defining feature is the massive, direct dopamine surge in reward circuits; this is not how cannabis works.

Question 4

Conditioned cues (such as lighters or social contexts associated with drug use) can trigger cravings months or years into abstinence, because the associative memories formed during use are stored durably.

• T. True
• F. False

Answer: True

Both stimulant and cannabis use disorders show high relapse potential via conditioned cues. During active use, the brain's associative learning systems assign enormous motivational value to drug-related cues. These associations are stored as durable memories independent of ongoing drug use — the drug is gone, but the learned salience of the cue remains. This is why relapse triggers are often environmental or social, not pharmacological, and why treatment focuses heavily on cue exposure and management.

Question 5

Cannabis use disorder is often undertreated partly because of a misconception about what defines addiction. What is that misconception, and why does cannabis challenge it?

Model answer: The misconception is that 'real' addiction requires severe physical withdrawal symptoms. Cannabis produces a milder withdrawal syndrome (irritability, sleep disruption, appetite changes) compared to opioids or alcohol, leading many to conclude cannabis isn't addictive. But addiction is defined by loss of control over use, continued use despite negative consequences (social, occupational, health), and functional impairment — criteria cannabis use disorder can fully meet regardless of withdrawal intensity.

This misconception has clinical consequences: patients and sometimes clinicians dismiss cannabis use patterns that would easily meet criteria for a use disorder if the drug were alcohol. The emphasis on withdrawal is historically tied to opioid and alcohol research; as cannabis disorders received more systematic study, the mismatch became clear. Treatment for cannabis use disorder is primarily behavioral — contingency management, CBT, motivational interviewing — and is effective, but only if the disorder is first recognized.